Articles with public access mandates - Trudy G OliverLearn more
Not available anywhere: 1
Epigenetic regulators open the door to SCLC plasticity
MC Weber, LT Izzo, TG Oliver
Cancer Research 83 (21), 3495-3497, 2023
Mandates: US National Institutes of Health
Available somewhere: 42
Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data
CM Rudin, JT Poirier, LA Byers, C Dive, A Dowlati, J George, JV Heymach, ...
Nature Reviews Cancer 19 (5), 289-297, 2019
Mandates: US National Institutes of Health, US Department of Veterans Affairs, Cancer …
MYC drives progression of small cell lung cancer to a variant neuroendocrine subtype with vulnerability to aurora kinase inhibition
G Mollaoglu, MR Guthrie, S Böhm, J Brägelmann, I Can, PM Ballieu, ...
Cancer cell 31 (2), 270-285, 2017
Mandates: US National Institutes of Health, German Research Foundation, Federal …
MYC drives temporal evolution of small cell lung cancer subtypes by reprogramming neuroendocrine fate
AS Ireland, AM Micinski, DW Kastner, B Guo, SJ Wait, KB Spainhower, ...
Cancer cell 38 (1), 60-78. e12, 2020
Mandates: US National Institutes of Health
Single-cell analyses reveal increased intratumoral heterogeneity after the onset of therapy resistance in small-cell lung cancer
CA Stewart, CM Gay, Y Xi, S Sivajothi, V Sivakamasundari, J Fujimoto, ...
Nature cancer 1 (4), 423-436, 2020
Mandates: US Department of Defense, US National Institutes of Health
Chronic cisplatin treatment promotes enhanced damage repair and tumor progression in a mouse model of lung cancer
TG Oliver, KL Mercer, LC Sayles, JR Burke, D Mendus, KS Lovejoy, ...
Genes & development 24 (8), 837-852, 2010
Mandates: US National Institutes of Health, Howard Hughes Medical Institute, German …
Small cell lung cancer tumors and preclinical models display heterogeneity of neuroendocrine phenotypes
W Zhang, L Girard, YA Zhang, T Haruki, M Papari-Zareei, V Stastny, ...
Translational lung cancer research 7 (1), 32, 2018
Mandates: US National Institutes of Health
Suppression of Rev3, the catalytic subunit of Polζ, sensitizes drug-resistant lung tumors to chemotherapy
J Doles, TG Oliver, ER Cameron, G Hsu, T Jacks, GC Walker, MT Hemann
Proceedings of the National Academy of Sciences 107 (48), 20786-20791, 2010
Mandates: US National Institutes of Health, Howard Hughes Medical Institute
Inosine monophosphate dehydrogenase dependence in a subset of small cell lung cancers
F Huang, M Ni, MD Chalishazar, KE Huffman, J Kim, L Cai, X Shi, F Cai, ...
Cell metabolism 28 (3), 369-382. e5, 2018
Mandates: US National Institutes of Health, Howard Hughes Medical Institute, V …
Caspase-2-mediated cleavage of Mdm2 creates a p53-induced positive feedback loop
TG Oliver, E Meylan, GP Chang, W Xue, JR Burke, TJ Humpton, ...
Molecular cell 43 (1), 57-71, 2011
Mandates: US National Institutes of Health, Howard Hughes Medical Institute
The lineage-defining transcription factors SOX2 and NKX2-1 determine lung cancer cell fate and shape the tumor immune microenvironment
G Mollaoglu, A Jones, SJ Wait, A Mukhopadhyay, S Jeong, R Arya, ...
Immunity 49 (4), 764-779. e9, 2018
Mandates: US National Institutes of Health, Damon Runyon Cancer Research Foundation
MYC-driven small-cell lung cancer is metabolically distinct and vulnerable to arginine depletion
MD Chalishazar, SJ Wait, F Huang, AS Ireland, A Mukhopadhyay, Y Lee, ...
Clinical Cancer Research 25 (16), 5107-5121, 2019
Mandates: US National Institutes of Health, V Foundation, USA, Lung Cancer Research …
New approaches to SCLC therapy: from the laboratory to the clinic
JT Poirier, J George, TK Owonikoko, A Berns, E Brambilla, LA Byers, ...
Journal of Thoracic Oncology 15 (4), 520-540, 2020
Mandates: US National Institutes of Health, National Health and Medical Research …
Response and resistance to NF-κB inhibitors in mouse models of lung adenocarcinoma
W Xue, E Meylan, TG Oliver, DM Feldser, MM Winslow, R Bronson, ...
Cancer discovery 1 (3), 236-247, 2011
Mandates: US National Institutes of Health, Howard Hughes Medical Institute
GLUT3 is induced during epithelial-mesenchymal transition and promotes tumor cell proliferation in non-small cell lung cancer
M Masin, J Vazquez, S Rossi, S Groeneveld, N Samson, PC Schwalie, ...
Cancer & metabolism 2, 1-14, 2014
Mandates: Swiss National Science Foundation
Recurrent WNT pathway alterations are frequent in relapsed small cell lung cancer
AH Wagner, S Devarakonda, ZL Skidmore, K Krysiak, A Ramu, L Trani, ...
Nature communications 9 (1), 3787, 2018
Mandates: US National Institutes of Health
Aurora-A kinase is essential for bipolar spindle formation and early development
DO Cowley, JA Rivera-Pérez, M Schliekelman, YJ He, TG Oliver, L Lu, ...
Molecular and cellular biology 29 (4), 1059-1071, 2009
Mandates: US National Institutes of Health
Sox2 cooperates with Lkb1 loss in a mouse model of squamous cell lung cancer
A Mukhopadhyay, KC Berrett, U Kc, PM Clair, SM Pop, SR Carr, BL Witt, ...
Cell reports 8 (1), 40-49, 2014
Mandates: US National Institutes of Health, Damon Runyon Cancer Research Foundation
Impaired Bub1 function in vivo compromises tension-dependent checkpoint function leading to aneuploidy and tumorigenesis
M Schliekelman, DO Cowley, R O'Quinn, TG Oliver, L Lu, ED Salmon, ...
Cancer research 69 (1), 45-54, 2009
Mandates: US National Institutes of Health
Protein expression of TTF1 and cMYC define distinct molecular subgroups of small cell lung cancer with unique vulnerabilities to aurora kinase inhibition, DLL3 targeting, and …
RJ Cardnell, L Li, T Sen, R Bara, P Tong, J Fujimoto, AS Ireland, ...
Oncotarget 8 (43), 73419, 2017
Mandates: US National Institutes of Health, LUNGevity Foundation, USA, V Foundation …
Publication and funding information is determined automatically by a computer program